erythromycin has been researched along with warfarin in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (39.29) | 18.7374 |
1990's | 7 (12.50) | 18.2507 |
2000's | 13 (23.21) | 29.6817 |
2010's | 14 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Ward, KW | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Fent, K; Popovic, M; Smital, T; Zaja, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Adebesin, AM; Falck, JR; Fischer, R; Konkel, A; Lossie, J; Paudyal, MP; Puli, N; Schunck, WH; Vijaykumar, J; Wesser, T; Westphal, C; Zhu, C | 1 |
Warkany, J | 1 |
Brenner, S; Elman, M; Wolf, R | 1 |
Hardesty, B; Ma, CH; Picking, WD; Picking, WL | 1 |
Cook, CE; Jagger, PI; Klauber, MR; Lorentz, SM; Townsend, RJ; Weibert, RT | 1 |
Raasch, RH | 1 |
Baciewicz, AM | 1 |
Golbus, MS; Goldberg, JD | 1 |
Nguyen, P; Pibouin, M; Renouard, A; Tillement, JP; Zini, R | 1 |
Bachmann, K | 1 |
Dibb, WL; Digranes, A; Salveson, A | 1 |
Altman, H; Howrie, DL; Maroon, TJ; Zitelli, BJ | 1 |
Hassell, D; Utt, JK | 1 |
Boyle, DA; Bussey, HI; Knodel, LC | 1 |
Fossati, C | 1 |
Jackson, RA; Smith, MC | 1 |
Bachmann, KA; Schwartz, JI | 1 |
Brown, SE; Gray, DR; Sato, RI | 1 |
Bachmann, K; Perrigo, E; Schwartz, J | 1 |
Husserl, FE | 1 |
Bachmann, K; Forney, R; Frogameni, A; Jauregui, LE; Schwartz, JI | 1 |
D'Arcy, PF | 1 |
Bartle, WR | 1 |
Barre, J; Campos, H; d'Athis, P; Prandota, J; Tillement, JP | 1 |
Buters, JT; Friedman, FK; Koley, AP; Markowitz, A; Robinson, RC | 1 |
Deeble, T; Wood, GD | 1 |
Inoue, K; Mimura, M; Nakamura, S; Oda, H; Ohmori, S; Shimada, T; Yamazaki, H | 1 |
Ariyaratnam, S; Pemberton, M; Sloan, P; Thakker, NS; Thornhill, MH | 1 |
Hirayama, F; Iizumi, Y; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
Gómez-López, T; Martínez-Quintas, MJ; Sanz, E | 1 |
Fowler, SM; Friedberg, T; Riley, RJ; Taylor, JM; Wolf, CR | 1 |
AMSTUTZ, P; BAROIS, A; GORCE, F; GOULON, M; RAPIN, M | 1 |
Fuhr, U; Kober, S; Mutschler, E; Spahn-Langguth, H; Zaigler, M | 1 |
Kreander, K; Tammela, P; Vuorela, P | 1 |
Chaudhary, A; Drijfhout, WJ; Garner, RC; Jochemsen, R; Kneer, J; Kuhnz, W; Lappin, G; Oosterhuis, B; Rowland, M | 1 |
Gerschutz, GP; Hoffmann, TK; Malone, PM; Parker, DL; Tucker, MA | 1 |
Horn, JR | 1 |
4 review(s) available for erythromycin and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sulfonamide-induced bullous hemorrhagic eruption in a patient with low prothrombin time.
Topics: Biopsy; Drug Eruptions; Drug Interactions; Eosinophils; Erythromycin; Female; Fluocortolone; Hematoma; Humans; Leukocytes, Mononuclear; Middle Aged; Mitral Valve Insufficiency; Neutrophils; Prothrombin Time; Respiratory Tract Infections; Skin Diseases, Vesiculobullous; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 1992 |
Carbamazepine drug interactions.
Topics: Carbamazepine; Cimetidine; Dextropropoxyphene; Drug Interactions; Erythromycin; Humans; Isoniazid; Lithium; Phenobarbital; Phenytoin; Primidone; Protein Binding; Troleandomycin; Valproic Acid; Warfarin | 1986 |
[Liver damage due to drugs. I].
Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline | 1974 |
1 trial(s) available for erythromycin and warfarin
Article | Year |
---|---|
Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Area Under Curve; Carbon Radioisotopes; Chromatography, Liquid; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Drug Monitoring; Erythromycin; Estradiol; Female; GABA Modulators; Humans; Injections, Intravenous; Male; Mass Spectrometry; Midazolam; Middle Aged; Warfarin | 2006 |
51 other study(ies) available for erythromycin and warfarin
Article | Year |
---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
Topics: Animals; Evolution, Molecular; Glycosylation; Gonadal Steroid Hormones; HEK293 Cells; Humans; Ion Transport; Organic Anion Transporters; Protein Multimerization; Zebrafish; Zebrafish Proteins | 2013 |
Development of Robust 17(
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arachidonic Acids; Dose-Response Relationship, Drug; Drug Stability; Epoxide Hydrolases; Esterification; Hepatocytes; Humans; Male; Mice; Microsomes, Liver; Myocardial Infarction; Myocytes, Cardiac; Rats, Sprague-Dawley; Rats, Wistar | 2019 |
A warfarin embryopathy?
Topics: Abnormalities, Drug-Induced; Alcoholism; Chondrodysplasia Punctata; Diazepam; Digitalis Glycosides; Erythromycin; Female; Fetus; Heart Valve Prosthesis; Heparin; Humans; Infant, Newborn; Penicillin G Benzathine; Pregnancy; Pregnancy Complications; Sulfisoxazole; Syphilis; Thrombosis; Warfarin | 1975 |
A synthetic alanyl-initiator tRNA with initiator tRNA properties as determined by fluorescence measurements: comparison to a synthetic alanyl-elongator tRNA.
Topics: Base Sequence; Coumarins; Erythromycin; Kinetics; Molecular Sequence Data; Nucleic Acid Conformation; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Peptide Initiation Factors; Poly U; Prokaryotic Initiation Factor-2; Protein Biosynthesis; Puromycin; Ribosomes; RNA, Transfer, Ala; RNA, Transfer, Met; Sparsomycin; Spectrometry, Fluorescence | 1991 |
Effect of erythromycin in patients receiving long-term warfarin therapy.
Topics: Adult; Aged; Drug Interactions; Erythromycin; Female; Humans; Male; Middle Aged; Prothrombin; Prothrombin Time; Radioimmunoassay; Stereoisomerism; Warfarin | 1989 |
Interactions of oral antibiotics and common chronic medications.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Allopurinol; Ampicillin; Antacids; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Digoxin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Sulfamethoxazole; Sulfonamides; Sulfonylurea Compounds; Tetracycline; Theophylline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 1987 |
The value of case reports in human teratology.
Topics: Abnormalities, Drug-Induced; Animals; Antiemetics; Dicyclomine; Doxylamine; Drug Combinations; Erythromycin; Female; Humans; Infant, Newborn; Isotretinoin; Medical Records; Pregnancy; Publishing; Pyridoxine; Teratogens; Thalidomide; Tretinoin; Warfarin | 1986 |
Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
Topics: Binding Sites; Blister; Blood Proteins; Diazepam; Erythrocytes; Erythromycin; Humans; Indomethacin; Methoxsalen; Protein Binding; Salicylates; Salicylic Acid; Warfarin | 1987 |
Screening for the influence of host factors on warfarin clearance using a single dose single sample procedure.
Topics: Adult; Drug Interactions; Erythromycin; Humans; Kinetics; Liver; Male; Metabolic Clearance Rate; Warfarin | 1986 |
Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
Topics: Aminocoumarins; Ampicillin; Anti-Bacterial Agents; Clindamycin; Cloxacillin; Coumarins; Doxycycline; Erythromycin; Gram-Positive Bacteria; Humans; Netilmicin; Penicillin G; Staphylococcus; Streptococcus; Vancomycin | 1986 |
Erythromycin-induced drug interactions. An illustrative case and review of the literature.
Topics: Carbamazepine; Child; Cyclosporins; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Metabolic Clearance Rate; Theophylline; Warfarin | 1987 |
Suspected interaction: warfarin and erythromycin.
Topics: Adult; Drug Interactions; Erythromycin; Humans; Male; Recurrence; Thrombophlebitis; Warfarin | 1985 |
Warfarin-erythromycin interaction.
Topics: Drug Interactions; Erythromycin; Humans; Warfarin | 1985 |
Relations between price and quality in community pharmacy.
Topics: Aspirin; Community Pharmacy Services; Contraceptives, Oral; Drug Interactions; Drug Prescriptions; Erythromycin; Fees, Pharmaceutical; Health Education; Mississippi; Pharmacists; Quality of Health Care; Thermometers; Warfarin | 1974 |
Erythromycin-warfarin interaction.
Topics: Drug Interactions; Erythromycin; Humans; Male; Warfarin | 1984 |
Warfarin interaction with erythromycin.
Topics: Drug Interactions; Erythromycin; Hemoptysis; Humans; Legionnaires' Disease; Male; Middle Aged; Warfarin | 1984 |
Interaction between warfarin and erythromycin.
Topics: Animals; Drug Interactions; Embolism; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Male; Middle Aged; Parotitis; Partial Thromboplastin Time; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors; Warfarin | 1983 |
Erythromycin-warfarin interaction.
Topics: Aged; Drug Synergism; Erythromycin; Humans; Male; Warfarin | 1983 |
The effect of erythromycin on the disposition kinetics of warfarin.
Topics: Adult; Drug Interactions; Erythromycin; Humans; Kinetics; Male; Metabolic Clearance Rate; Warfarin | 1984 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Possible warfarin-erythromycin interaction.
Topics: Aged; Drug Synergism; Erythromycin; Female; Humans; Warfarin | 1980 |
Binding of erythromycin base to human plasma proteins.
Topics: Aspirin; Bilirubin; Blood Proteins; Erythromycin; Furosemide; Humans; Hydrogen-Ion Concentration; Orosomucoid; Phenylbutazone; Protein Binding; Serum Albumin; Temperature; Warfarin | 1980 |
CO binding kinetics of human cytochrome P450 3A4. Specific interaction of substrates with kinetically distinguishable conformers.
Topics: Animals; Carbon Monoxide; Cimetidine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Ethinyl Estradiol; Humans; Kinetics; Mixed Function Oxygenases; Nifedipine; Protein Binding; Quinidine; Recombinant Proteins; Spodoptera; Substrate Specificity; Testosterone; Time Factors; Transfection; Warfarin | 1995 |
Warfarin: dangers with antibiotics.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acids; Dental Care for Chronically Ill; Drug Interactions; Erythromycin; Female; Humans; Male; Middle Aged; Warfarin | 1993 |
Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
Topics: Adrenergic beta-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Benzphetamine; Carcinogens; Coumarins; Cytochrome P-450 Enzyme System; Dogs; Erythromycin; Ethanolamines; Ethylmorphine; Guinea Pigs; Humans; Macaca fascicularis; Mephenytoin; Microsomes, Liver; Nifedipine; Oxazines; Oxidation-Reduction; Phenacetin; Phenytoin; Rats; Species Specificity | 1997 |
Treating oral candidiasis: potentially fatal.
Topics: Anti-Bacterial Agents; Anticoagulants; Antifungal Agents; Candidiasis, Oral; Drug Interactions; Erythromycin; Fluconazole; Humans; Warfarin | 1997 |
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Antifibrinolytic Agents; Blood Coagulation; Carbamazepine; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Male; Mice; Mice, Inbred ICR; Partial Thromboplastin Time; Phenytoin; Piperidines; Prothrombin Time; Rifampin; Sulfonamides; Thromboembolism; Thromboplastin; Vitamin K 1; Warfarin | 1998 |
Perception of teratogenic risk of common medicines.
Topics: Abnormalities, Drug-Induced; Chi-Square Distribution; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Health Knowledge, Attitudes, Practice; Humans; Physicians; Pregnancy; Risk Factors; Students, Medical; Teratogens; Warfarin | 2001 |
CYP3A4 active site volume modification by mutagenesis of leucine 211.
Topics: Amino Acid Substitution; Anti-Anxiety Agents; Anti-Bacterial Agents; Binding Sites; Coumarins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diazepam; Enzyme Activation; Enzyme Inhibitors; Erythromycin; Hydroxylation; Kinetics; Leucine; Mixed Function Oxygenases; Mutagenesis, Site-Directed; Oxidation-Reduction; Structure-Activity Relationship; Substrate Specificity; Testosterone; Troleandomycin | 2002 |
[ANURIA CAUSED BY ACUTE INTERSTITIAL NEPHROPATHY IN THE COURSE OF PROLONGED PHENINDIONE TREATMENT].
Topics: Anuria; Chloramphenicol; Coma; Coumarins; Dermatitis; Diagnosis; Dialysis; Eosinophils; Erythromycin; Fever; Isoniazid; Methicillin; Nephritis; Nephritis, Interstitial; Pathology; Penicillins; Peritoneal Cavity; Phenindione; Renal Dialysis; Streptomycin; Toxicology | 1964 |
Rate-limiting biotransformation of triamterene is mediated by CYP1A2.
Topics: Caffeine; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Humans; Hydroxylation; Ketoconazole; Kinetics; Microsomes, Liver; Omeprazole; Quinidine; Substrate Specificity; Sulfuric Acid Esters; Theophylline; Triamterene | 2005 |
A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin.
Topics: Anti-Bacterial Agents; Coumarins; Drug Resistance, Bacterial; Erythromycin; Finland; Flavonoids; Gallic Acid; Humans; Hydroxybenzoates; Microbial Sensitivity Tests; Nephelometry and Turbidimetry; Penicillin G; Staphylococcus; Streptococcus pyogenes; Time Factors | 2005 |
Elevated International Normalized Ratio associated with concurrent use of ophthalmic erythromycin and warfarin.
Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Drug Synergism; Erythromycin; Female; Humans; International Normalized Ratio; Ophthalmic Solutions; Warfarin | 2010 |
Analysis of purported erythromycin-warfarin interaction.
Topics: Anti-Bacterial Agents; Anticoagulants; Drug Interactions; Erythromycin; Humans; Liver; Ointments; Ophthalmic Solutions; Warfarin | 2010 |